Neuroone Medical Technologies (NMTC) Short term Debt (2016 - 2024)
Neuroone Medical Technologies (NMTC) posted Short term Debt of $121896.0 for Q1 2024, down 5.59% on a QoQ basis from $129116.0 in Q3 2023.
Neuroone Medical Technologies (NMTC) Short term Debt (2016 - 2024) Analysis & Trends
Neuroone Medical Technologies' Short term Debt history runs 6 years deep, the most recent figure standing at $121896.0 for Q1 2024.
- Quarterly Short term Debt changed N/A year-over-year to $121896.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $121896.0 (changed N/A YoY) and the FY2023 annual result came in at $129116.0, changed N/A from the prior year.
- Short term Debt was $121896.0 for Q1 2024 at Neuroone Medical Technologies, down from $129116.0 in the prior quarter.
- Across five years, Short term Debt topped out at $129116.0 in Q3 2023 and bottomed at $121896.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 121,896.00 |
| Sep 30, 2023 | 129,116.00 |
| Mar 31, 2019 | 229,000.00 |
| Dec 31, 2018 | 528,000.00 |
| Sep 30, 2018 | 283,000.00 |
| Jun 30, 2018 | 283,000.00 |
| Mar 31, 2018 | 369,124.00 |
| Dec 31, 2017 | 253,000.00 |
| Sep 30, 2017 | 204,074.00 |
| Dec 31, 2016 | 50,000.00 |